Sodium nitroprusside intravenous - Exela Pharma SciencesAlternative Names: NIPRIDE RTU; Sodium nitroprusside - RTU
Latest Information Update: 10 Mar 2017
At a glance
- Originator Exela Pharma Sciences
- Class Antihypertensives; Heart failure therapies; Peripheral vasodilators
- Mechanism of Action Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Registered Acute heart failure